‘This story originally appeared on MedTech Actuator.’
MedTech Actuator Menzies Fellow Dr Warwick Nesbitt is fusing research with entrepreneurship to help reduce the prevalence and impact of cardiovascular disease.
Unlocking The Potential Of Lab-On-A-Chip Technologies
Warwick is the Laboratory Head of the Haematology Micro-platforms Group, based within the Australian Centre for Blood Disease at Monash University. His multidisciplinary group focuses on the development of novel lab-on-a-chip technologies. These technologies have applications in:
- basic haematology / cell biology research
- new diagnostics in thrombosis and haemostasis
- new antithrombotic drug discovery.
Making A Difference To Heart Attack And Stroke Patients
Warwick says that a key inspiration for developing the lab-on-a-chip technologies is the prevalence and impact that cardiovascular diseases – particularly heart attack and stroke – have on the community. “Having had family members’ quality of life impacted through the devastating effects of stroke, I am keenly aware of the need for better diagnostics and therapeutics in this area of medicine,” says Warwick.
“My hope is that by developing better tests of blood function, we can improve the clinical management of cardiovascular disease patients.”
Research x Entrepreneurship With The MedTech Actuator Menzies Fellowship
Warwick became a MedTech Actuator Menzies Fellow to develop a better understanding of the MedTech landscape in Australia and internationally.
“I am excited to access the experience, expertise, and networks necessary to commercialise our lab-on-a-chip technologies.”
As a MedTech Actuator Menzies Fellow, Warwick is building expertise in entrepreneurship, commercialisation, and the startup ecosystem. This support will help to unlock the potential in his research and embed the novel lab-on-a-chip technologies in clinical practice to improve and save lives. Through the Fellowship, Warwick receives mentorship from industry experts, a $20K stipend, networking opportunities and invitations to exclusive events.
Our Network Is Warwick’s Network For Life
As a MedTech Actuator Menzies Fellow, our network becomes Warwick’s network – not just throughout the program, but for life. He joins our community of:
- The brightest MedTech, HealthTech and BioTech founders across Asia Pacific in the MedTech Actuator Accelerator
- MedTech Actuator’s extensive ecosystem of partners spanning hospitals, product development firms, multinational corporations, and investors
- MedTech Actuator Menzies Scholars and Fellows
- MedTech Actuator Origin entrepreneurs
Are you a future MedTech Actuator Menzies Fellow?
If you’re a senior researcher in human health at an Australian university or research institute, the prestigious MedTech Actuator Menzies Fellowship can help you to transform your research impact.
Get ready to fuse your research and science expertise with entrepreneurship – applications for the MedTech Actuator Menzies Fellowship 2023 will open in the coming months.
Women and applicants from diverse backgrounds are strongly encouraged to apply for our 2023 intake. We want to hear from you and would love to chat if you have questions – reach out below.
Visit MedTech Actuator to register your interest for the next program.
